4,4'-Dimethoxybenzil_HNMR_26422_MedChemExpress
- 格式:pdf
- 大小:178.83 KB
- 文档页数:1
二乙基四甲基咪唑的制备
二乙基四甲基咪唑,英文简称为DEMI,是一种常用于高分子化学合成反应体系中的离子液体。
其合成方法比较简单,可以通过以下步骤实现:
首先,将甲基异丙醇加入含盐溶液中,使得盐在溶剂中完全溶解;接着,加入氧化氢和氯丁酸铜等催化剂,使反应开始进行;然后,加入适量的二甲基咪唑,在加热和搅拌的情况下反应约15小时;最后,用醚提取产物,并用氯仿和水洗涤,去除水和杂质。
得到的纯品即为二乙基四甲基咪唑。
需要注意的是,在整个合成过程中,操作要非常谨慎,避免发生危险。
此外,在提取产物时,也需要特别小心,以避免对身体造成伤害。
总的来说,二乙基四甲基咪唑的制备过程并不是一件难事,但需要进行认真而细致的操作。
只有在安全和科学的前提下,才能获得高质量的产品,为化学研究提供帮助。
Product Information MINIMUM ESSENTIAL MEDIUM EAGLED-VALINE MODIFICATIONProduct Number M7395Storage Temperature 2-8°CProduct DescriptionMinimum Essential Medium (MEM), developed by Harry Eagle, is one of the most widely used of all synthetic cell culture media. Early attempts to cultivate normal mammalian fibroblasts and certain subtypes of HeLa cells revealed that they had specific nutritional requirements that could not be met by Eagle’s Basal Medium (BME). Subsequent studies using these and other cells in culture indicated that additions to BME could be made to aid growth of a wider variety of fastidious cells. MEM, which incorporates these modifications, includes higher concentrations of amino acids. MEM has been used for cultivation of a wide variety of cells grown in monolayers. Optional supplementation of non-essential amino acids to the formulations that incorporate either Hanks’ or Earle’s salts has broadened the usefulness of this medium. The formulation has been further modified by optional elimination of calcium to permit growth of cells in suspension culture.MINIMUM ESSENTIAL MEDIUM EAGLE, Product No. M 7395 is one of the cell culture media available from Sigma. The selection of a nutrient medium is strongly influenced by 1] type of cell, 2] type of culture [monolayer, suspension, clonal] and 3] degree of chemical definition necessary. It is important to review the literature for recommendations concerning medium, supplementation and physiological parameters required for a specific cell line.Components g/L Calcium Chloride•2H2O0.265 Magnesium Sulfate (anhydrous)0.09767 Potassium Chloride0.4 Sodium Chloride 6.8 Sodium Phosphate Monobasic0.122 (anhydrous)L-Arginine•HCl0.126L-Cystine•2HCl0.0313 L-Glutamine0.292L-Histidine•HCl•H2O0.042L-Isoleucine0.052L-Leucine0.052L-Lysine•HCl0.0725 L-Methionine0.015L-Phenylalanine0.032L-Threonine0.048L-Tryptophan0.01L-Tyrosine•2Na•2H2O0.0519D-Valine0.092 Choline Chloride0.001Folic Acid0.001myo-Inositol0.002 Niacinamide0.001D-Pantothenic Acid (hemicalcium)0.001 Pyridoxal•HCl0.001 Riboflavin0.0001 Thiamine•HCl0.001 Glucose 1.0 Phenol Red•Na0.011Precautions and DisclaimerREAGENTFor In Vitro Diagnostic UsePreparation InstructionsPowdered media are extremely hygroscopic and should be protected from atmospheric moisture. The entire contents of each package should be used immediately after opening. Preparing a concentrated solution of medium is not recommended as precipitates may form. Supplements can be added prior to filtration or introduced aseptically to sterile medium. The nature of the supplement may affect storage conditions and shelf life of the medium.1.Measure out 90% of final required volume ofwater. Water temperature should be 15-20°C.2.While gently stirring the water, add thepowdered medium. Stir until dissolved. Do NOTheat.3.Rinse original package with a small amount ofwater to remove all traces of powder. Add tosolution in step 2.4.To the solution in step 3, add 2.2 g sodiumbicarbonate or 29.3 ml of sodium bicarbonatesolution [7.5%w/v] for each liter of final volumeof medium being prepared. Stir until dissolved.5.While stirring, adjust the pH of the medium to0.1-0.3 pH units below the desired pH since itmay rise during filtration. The use of 1N HCl or1N NaOH is recommended.6.Add additional water to bring the solution tofinal volume.7.Sterilize immediately by filtration using amembrane with a porosity of 0.22 microns.8.Aseptically dispense medium into sterilecontainer.Storage/StabilityStore the dry powdered medium at 2-8°C under dry conditions and liquid medium at 2-8°C in the dark. Deterioration of the powdered medium may be recognized by any or all of the following: [1] color change, [2] granulation/clumping, [3] insolubility. Deterioration of the liquid medium may be recognized by any or all of the following: [1] pH change, [2] precipitate or particulate matter throughout the solution, [3] cloudy appearance [4] color change. The nature of supplements added may affect storage conditions and shelf life of the medium. Product label bears expiration date.ProcedureWater for tissue culture use [W-3500]Sodium Bicarbonate [S-5761] orSodium Bicarbonate Solution, 7.5% [S-8761]1N Hydrochloric Acid [H-9892]1N Sodium Hydroxide [S-2770]Medium additives as requiredProduct ProfileAppearance off-white powder Moisture content 2.0% Solubility clear solution at 1x concentrationpH at room temperature 5.8 ± 0.3 [without sodium bicarbonate]pH at room temperature 7.5 ± 0.3 [with sodium bicarbonate]Osmolality250 mOsm/kg H2O ± 5% [without sodium bicarbonate]Osmolality290 mOsm/kg H2O ± 5% [with sodium bicarbonate]Amino Acid Analysis Analysis has confirmedby HPLC that amino acids are present atconcentrations consistent withthe formula.Key Element Analysis Analysis has confirmed that by ICAP key elements are present atconcentrations consistent withthe formula.BIOLOGICAL PERFORMANCE CHARACTERISTICS Biological performance is assessed using an appropriate cell line(s). Growth studies are carried through 2 subculture generations. Cells are counted and growth is plotted as a logarithmic function of time in culture. Seeding efficiencies, doubling time, and final cell densities are determined. During the testing period cultures are examined microscopically for atypical morphology and evidence of cytotoxicity. Test results are available upon request.References1.Eagle, H. et al (1956) myo-Inositol as anEssential Growth Factor for Normal andMalignant Human Cells in Tissue Culture.J.Biol. Chem. 214, 845-847.2.Eagle, H.(1976) Media for Animal Cell Culture.Tissue Culture Association Manual. 3, 517-520.3.Eagle, H. (1959). Amino Acid Metabolism inMammalian Cell Cultures. Science. 130, 432-437.4.Eagle, H. (1955) Nutrition Needs of MammalianCells in Culture. Science. 122, 501.5.Gilbert, S.F. and Migeon, B.R. (1975) D-valineas a selective agent for normal human androdent epithelial cells in culture. Cell. 5, 11-17.7H027Sigma brand products are sold through Sigma-Aldrich, Inc.Sigma-Aldrich, Inc. warrants that its products conform to the information contained in this and other Sigma-Aldrich publications. Purchaser must determine the suitability of the product(s) for their particular use. Additional terms and conditions may apply. Please see reverse side ofthe invoice or packing slip.。
依泽替米贝文献综述一. 前言1.1背景随着我国人民生活水平的不断提高,饮食结构的改变导致人类疾病结构的改变,高脂血症已呈高发病趋势。
自上世纪末以来,美国每年有120万患急性心肌梗死,死亡总人口中,1/3死于冠心病。
据统计,我国成人血脂异常患病率为 18.6%,年发病率为560/10万,全国血脂异常现患人数为1.6亿。
而高血脂又是冠心病、动脉硬化、心肌梗死的重要病因之一,并能够加重高血压、糖尿病、脂肪肝、肝硬化、胰腺炎等疾病的病情恶化,严重威胁着人们的生命安全,成为威胁人类健康的劲敌。
降血脂药物进展研究和发展新型降血脂药物具有重大的社会效益和经济效益,因此降血脂药物的开发和应用一直是医学界的热点领域1.2依替米贝概述依泽替米贝是由默克(Merck)和先灵葆雅公司共同开发的一种新型的抑制胆固醇吸收的降血脂药物。
依泽替米贝中文名1-(4-氟苯基)-(3R)-[3-(4-氟苯基)-(3S)-羟基丙基]-(4S)-(4-羟基苯基)-2-丙内酰胺英文名:Ezetimibe结构式:分子式:C24H21F2NO3分子量:409.43CAS:163222-33-1对眼睛、呼吸道和皮肤有刺激作用依泽替米贝为白色结晶性粉末,极易溶于乙醇、甲醇和丙酮,不溶于水,熔点约为163℃,在常温下稳定。
依替米贝能够通过抑制小肠刷状缘TC吸收而降低血Te,它本身也具有微弱的调血脂作用。
口服吸收后,与葡萄糖醛酸苷结合生成活性物质一依泽替米贝一葡萄糖醛酸苷,经胆汁和肾排泄。
口服后在4~12h 内达血药峰浓度,Cmax为3.4~5.5 mg/l,生物利用度在35%~60%之间,T1/2约为22h。
依替米贝及依替米贝一葡萄糖醛酸苷与血浆蛋白结合率高于90%。
依泽替米贝是一类新型的选择性胆固醇吸收抑制剂,通过与小肠刷状缘膜小囊泡上膜蛋白结合后,抑制小肠对饮食中和经胆汁输送到肠道中的胆固醇的吸收,降低血清和肝脏中的胆固醇含量,降低血浆低密度脂蛋白分数。
亚甲基双-苯并三唑基四甲基丁基酚结构式解释说明1. 引言1.1 概述亚甲基双-苯并三唑基四甲基丁基酚(Methyl-Bis(phenylthiobenzotriazolyl)-4-methylpiperidinol)是一种重要的有机化合物,具有广泛的应用领域和潜在的研究价值。
该化合物以其独特的结构和性质而备受关注。
本文将详细介绍亚甲基双-苯并三唑基四甲基丁基酚的定义、结构式解释及其特点,探讨其在药物研究与开发、化学工业中的用途以及环境监测和分析方法方面的应用。
此外,我们还将讨论制备亚甲基双-苯并三唑基四甲基丁基酚的方法和工艺参数对产率与纯度的影响,并探索可能存在的改进和优化方向。
最后,本文将总结亚甲基双-苯并三唑基四甲基丁基酚的重要性和应用价值,并对未来发展趋势进行展望。
1.2 文章结构本文共包括引言、亚甲基双-苯并三唑基四甲基丁基酚的定义与特点、亚甲基双-苯并三唑基四甲基丁基酚的应用领域、制备亚甲基双-苯并三唑基四甲基丁基酚的方法与工艺参数控制以及结论与展望等五个部分。
下面将对每个部分的内容进行详细阐述。
1.3 目的本文旨在全面介绍亚甲基双-苯并三唑基四甲基丁基酚这一化合物的相关知识,包括其定义、结构式解释和特点,并深入探讨其在药物研究与开发、化学工业以及环境监测和分析方法方面的应用。
此外,我们还将探讨制备该化合物的方法和工艺参数对产率与纯度的影响,并提出可能存在的改进和优化方向。
最后,本文将总结该化合物的重要性和应用价值,并对未来发展趋势进行展望。
通过本文的研究,希望能够加深对亚甲基双-苯并三唑基四甲基丁基酚这一化合物的认识,并促进相关领域研究和产业应用的进一步发展。
2. 亚甲基双-苯并三唑基四甲基丁基酚的定义与特点2.1 定义:亚甲基双-苯并三唑基四甲基丁基酚是一种有机化合物,化学式为C21H23N5O。
它由一个亚甲基(CH2)连接两个苯并三唑环,并且具有四个甲基和一个丁基取代在苯并三唑环上。
人4-羟基壬烯醛(4-HNE)试剂盒(ELISA)使用说明书●本试剂盒用于体外定量检测血清、血浆、组织、细胞上清及相关液体样本中人4-羟基壬烯醛(4-HNE)的含量。
●有效期:6个月●保存条件:2-8℃●本试剂盒仅供体外研究使用,不用于临床诊断试剂盒采用双抗体一步夹心法酶联免疫吸附试验(ELISA)。
往预先包被人4-羟基壬烯醛(4-HNE)捕获抗体的包被微孔中,依次加入标本、标准品、HRP标记的检测抗体,经过温育并彻底洗涤。
用底物TMB显色,TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。
颜色的深浅和样品中的人4-羟基壬烯醛(4-HNE)呈正相关。
用酶标仪在450nm 波长下测定吸光度(OD 值),计算样品浓度。
1. 血清:全血标本请于室温放置2小时或4℃过夜后于1000g离心20分钟,取上清即可检测,或将标本放于-20℃或-80℃保存,但应避免反复冻融。
2. 血浆:可用EDTA或肝素作为抗凝剂,标本采集后30分钟内于2 - 8°C 1000g离心20分钟,或将标本放于-20℃或-80℃保存,但应避免反复冻融。
3. 组织匀浆:用预冷的PBS (0.01M, pH=7.4)冲洗组织,去除残留血液(匀浆中裂解的红细胞会影响测量结果),称重后将组织剪碎。
将剪碎的组织与对应体积的PBS(一般按1:9的重量体积比,比如1g的组织样品对应9mL的PBS,具体体积可根据实验需要适当调整,并做好记录。
推荐在PBS中加入蛋白酶抑制剂)加入玻璃匀浆器中,于冰上充分研磨。
为了进一步裂解组织细胞,可以对匀浆液进行超声破碎,或反复冻融。
最后将匀浆液于5000×g离心5~10分钟,取上清检测。
4. 细胞培养物上清或其它生物标本:1000g离心20分钟,取上清即可检测,或将标本放于-20℃或-80℃保存,但应避免反复冻融。
注:标本溶血会影响最后检测结果,因此溶血标本不宜进行此项检测。
消化道多巴胺及其代谢酶的功能研究摘要:多巴胺(dopamine, DA)是一种广泛存在于中枢神经系统和外周组织的儿茶酚胺类神经递质,其功能越来越受到学者们的关注,尤其是近年发现DA可以调节免疫系统功能,DA与肠黏膜炎症相关疾病联系的研究成为热点。
消化道是外周DA的重要来源,DA 不仅产生于肠神经系统和消化道上皮等部位,而且还大量产自于肠道微生物。
机体组织中DA的含量变化除了受其合成酶影响外,还受到两个重要的代谢酶单胺氧化酶(monoamine oxidase,MAO)和儿茶酚-O-甲基转移酶(catechol-O-methyltransferase,COMT)的调控。
本文主要对消化道DA的来源和功能、DA代谢酶的分布和功能进行综述。
关键词:消化道; 多巴胺; 单胺氧化酶; 儿茶酚氧位甲基转移酶;Abstract:Dopamine(DA), as a catecholamine neurotransmitter widely distributed in the central nervous system and the peripheral tissues, has attracted a lot of attention. Especially in recent years, DA has been found to regulate the function of the immune system, and the involvement of DA in the intestinal mucosal inflammation-related diseases has become a hot research topic. The digestive tract is an important source of peripheral DA, and DA is not only produced in the enteric nervous system and gastrointestinal epithelium, but also produced by intestinal microorganisms. In addition to the synthetases of DA, the DA contents in body tissues are also affected by the two kinds of metabolic enzymes, monoamine oxidase(MAO) and catechol-O-methyltransferase(COMT). This article reviewed the sources, metabolism and functions of DA in digestive tract, especially focusing on the distribution and function of MAO and COMT, the enzymes degrading DA.Keyword:gastrointestinal tract; dopamine; monoamine oxidase; catechol-O-methyltransferase;多巴胺(dopamine,DA)是一种重要的单胺类神经递质,不仅在中枢神经系统发挥调控运动、认知、情绪、记忆和奖赏等作用,在外周组织,尤其胃肠道中也发挥重要作用,包括保护胃肠黏膜,调节黏膜离子分泌,调节胃肠动力等。
2022年修订第一版(本试剂盒仅供体外研究使用,不用于临床诊断!)产品货号:E-EL-0128c产品规格:96T/48T/24T/96T*5Elabscience 4-羟基壬烯酸(4-HNE)酶联免疫吸附测定试剂盒使用说明书4-HNE(4-Hydroxynonenal) ELISA Kit使用前请仔细阅读说明书。
如果有任何问题,请通过以下方式联系我们:销售部电话技术部电话************电子邮箱(销售)********************电子邮箱(技术)**************************网址:具体保质期请见试剂盒外包装标签。
请在保质期内使用试剂盒。
联系时请提供产品批号(见试剂盒标签),以便我们更高效地为您服务。
Copyright ©2021-2022 Elabscience Biotechnology Co.,Ltd. All Rights Reserved目录用途 (3)基本性能 (3)检测原理 (3)试剂盒组成及保存 (4)试验所需自备物品 (5)样品收集方法 (5)注意事项 (6)■ 试剂盒注意事项 (6)■ 样品注意事项 (6)样本稀释方案 (6)检测前准备工作 (7)操作步骤 (8)结果判断 (10)技术资源 (10)典型数据 (10)性能 (11)■ 精密度 (11)■ 回收率 (11)■ 线性 (11)声明 (12)Intended use (13)Character (13)Test principle (13)Kit components & Storage (14)Other supplies required (15)Sample collection (15)Note (16)■ Note for kit (16)■ Note for sample (16)Dilution Method (17)Reagent preparation (17)Assay procedure (18)Calculation of results (20)Technical resources (20)Typical data (20)Performance (21)■ Precision (21)■ Recovery (21)■ Linearity (21)Declaration (22)用途该试剂盒用于体外定量检测 血清、血浆或其他相关生物液体中4-HNE浓度。